Exportar Publicação

A publicação pode ser exportada nos seguintes formatos: referência da APA (American Psychological Association), referência do IEEE (Institute of Electrical and Electronics Engineers), BibTeX e RIS.

Exportar Referência (APA)
Bravo, A. & Crespo de Carvalho, J. (2015). Challenging times to pharmaceutical supply chains towards sustainability: a case study application. International Journal of Procurement Management. 8 (1/2), 126-140
Exportar Referência (IEEE)
A. M. Bravo and J. L. Carvalho,  "Challenging times to pharmaceutical supply chains towards sustainability: a case study application", in Int. Journal of Procurement Management, vol. 8, no. 1/2, pp. 126-140, 2015
Exportar BibTeX
@article{bravo2015_1714974406400,
	author = "Bravo, A. and Crespo de Carvalho, J.",
	title = "Challenging times to pharmaceutical supply chains towards sustainability: a case study application",
	journal = "International Journal of Procurement Management",
	year = "2015",
	volume = "8",
	number = "1/2",
	doi = "10.1504/IJPM.2015.066292",
	pages = "126-140",
	url = "http://www.inderscienceonline.com/toc/ijpm/8/1-2"
}
Exportar RIS
TY  - JOUR
TI  - Challenging times to pharmaceutical supply chains towards sustainability: a case study application
T2  - International Journal of Procurement Management
VL  - 8
IS  - 1/2
AU  - Bravo, A.
AU  - Crespo de Carvalho, J.
PY  - 2015
SP  - 126-140
SN  - 1753-8432
DO  - 10.1504/IJPM.2015.066292
UR  - http://www.inderscienceonline.com/toc/ijpm/8/1-2
AB  - The pharmaceutical industry is one of the most high tech industries dedicated to quality, headed for the compliance fulfilment of regulatory bodies. Nevertheless, the increase of returns and recalls that is taking place, suggests the change in paradigm that is happening in this industry. Therefore, this paper is the combination of findings of previous literature reviews conducted by the authors with the application of a case study. In particular, we explore the links between pharmaceutical drugs quality, reverse logistics, and sustainability. With this approach we expect the deeper understanding on the type of returns companies receive, especially from hospital pharmacies. Consequently, it is anticipated to link both parties in the application of a quality by design risk management approach as well as reduce variability and risk of non-compliance.

ER  -